Plain-English translation of NCT07172243 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry and sample collection study for people with amyloidosis, a rare disease where abnormal proteins build up in the body. Researchers are creating a central database and storage system for blood and tissue samples from amyloidosis patients to help scientists understand the disease better and develop better treatments in the future.
Amyloidosis is complex with many different types, and doctors need better information about how the disease progresses and how patients respond to treatment. By collecting samples and health information from many patients in one place, researchers hope to discover new insights that will improve care and outcomes.
You likely qualify if…
You likely don't qualify if…
If you join, you will donate blood and possibly tissue samples for storage and future research. You will also allow researchers to collect and store your personal and medical information — including your diagnosis, treatment history, and how you respond to treatment — in a secure database. The study will follow you over time to track how your disease progresses and evolves.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Belgium
Flemish institute of biotechnology (VIB)
Enrollment target
~505 participants
Started
September 2025
Primary completion
September 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Michel Delforge
UZ Leuven Gasthuisberg
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.